TETRAHYDROISOCHINOLIN DERIVATE

European patent · EP3442945 · In force

Register entry

Publication number
EP3442945
Application number
EP17714837
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Apr 7, 2017
Published
Feb 20, 2019
Granted
Jul 8, 2020
Protection ends at the latest
Apr 6, 2037
Next annual fee due
Apr 30, 2027
IPC classes
C07D 217/06 (2006.01)
C07D 401/06 (2006.01)
C07D 403/06 (2006.01)
A61K 31/472 (2006.01)
Priority
EP 16165012 13.04.2016
PCT application
PCT/EP2017/058422 07.04.2017
PCT publication
WO2017/178377 19.10.2017
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. May 1, 2026

    Change

    Published in Swissreg on 01.05.2026

  2. May 1, 2025

    Change

    Published in Swissreg on 01.05.2025

  3. May 1, 2024

    Change

    Published in Swissreg on 01.05.2024

  4. May 1, 2023

    Change

    Published in Swissreg on 01.05.2023

  5. Jul 8, 2020

    Granted

    Published in Swissreg on 08.07.2020

Parties

Holder

UCB Biopharma SRL

Allée de la Recherche 60, 1070 Brussels, BE

Inventor

JNOFF, Eric

1070 Brussels, BE

VALADE, Anne

1070 Brussels, BE

HALL, Adrian

1070 Brussels, BE

PROVINS, Laurent

1070 Brussels, BE

ATES, Ali

1070 Brussels, BE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.